The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility

Type: Retraction
Notice date: 3/19/2012 0:00
Journal: PNAS: Proceedings of the National Academy of Sciences of the United States of America
Publisher: National Academy of Sciences (NAS)
Notice DOI: 10.1073/pnas.1203736109
Original paper DOI: 10.1073/pnas.0709477105

Reasons